Telesat reports Q4 loss amid heavy lightspeed infrastructure investment
Telesat (NASDAQ:TSAT) reported a net loss of $90.1 million for the fourth quarter ended December 31, 2025.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Telesat (NASDAQ:TSAT) reported a net loss of $90.1 million for the fourth quarter ended December 31, 2025.
Mastercard (NYSE:MA) today signaled a major shift in the global payments landscape by announcing the acquisition of BVNK, a prominent provider of stablecoin and digital asset infrastructure.
Neuronetics (NASDAQ:STIM), the leader in Transcranial Magnetic Stimulation (TMS) therapy for mental health, reported its fourth-quarter and full-year 2025 financial results, reflecting the transformative impact of its late-2024 acquisition of Greenbrook TMS.
Corporación América Airports (NYSE:CAAP), one of the world's largest private airport operators, delivered a strong finish to fiscal 2025, characterized by robust top-line growth and a dramatic expansion in profitability.
CervoMed (NASDAQ:CRVO) announced on Tuesday that it has achieved critical regulatory and clinical alignment for the Phase 3 development of neflamapimod, its oral small-molecule treatment for dementia with Lewy bodies (DLB).
Abeona Therapeutics (NASDAQ:ABEO) on Wednesday reported financial results for the full year ended December 31, 2025, and provided operational updates centered on the commercial launch of its lead gene therapy ZEVASKYN.
X4 Pharmaceuticals (NASDAQ:XFOR) reported its fourth-quarter and full-year 2025 financial results on March 17, 2026, marking a year of transition from a clinical-stage entity to a commercial-revenue-generating firm.
Victory Capital Holdings (NASDAQ:VCTR) increased the pressure on Janus Henderson Group (NYSE:JHG) today, submitting an enhanced acquisition proposal to the company’s Special Committee.
GDS Holdings (NASDAQ:GDS) reported audited financial results for the fourth quarter and full year ended December 31, 2025, demonstrating resilient growth in its hyperscale data center operations.
Steel Dynamics (NASDAQ:STLD) provided a bullish outlook for the first quarter of 2026, signaling a significant acceleration in profitability compared to both the previous quarter and the prior year.
Pfizer (NYSE:PFE) reported a significant clinical milestone in its oncology pipeline today, announcing that the Phase 2 FOURLIGHT-1 study of atirmociclib met its primary endpoint.
Citi Trends (NASDAQ:CTRN) reported a robust recovery for the fourth quarter ended January 31, 2026, marking a pivotal turn for the off-price retailer.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade